MEDIOX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIOX
Largest movements
- Receivables within one year +€34,548
up €34,548 (+20.7%), from €167,246 to €201,794
of which Trade receivables: +€36,253
- Cash -€32,290
down €32,290 (-71.6%), from €45,128 to €12,838
mainly Receivables within one year (-€34,548) and Other debts (-€26,120)
- Trade debts +€34,395
up €34,395 (+157%), from €21,905 to €56,299
- Other debts -€26,120
down €26,120 (-50.6%), from €51,661 to €25,541
- Profit (loss) carried forward -€6,017
down €6,017 (-5.1%), from €118,357 to €112,340
- Gross operating margin -€36,705
down €36,705, from €31,327 to -€5,378
- Taxes -€7,588
down €7,588 (-100%), from €7,588 to €0
- Other operating charges -€515
down €515 (-71.3%), from €723 to €208
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €212,374 | €214,632 | +€2,258 | +1.1% |
| Current assets | 29/58 | €212,374 | €214,632 | +€2,258 | +1.1% |
| Amounts receivable within one year | 40/41 | €167,246 | €201,794 | +€34,548 | +20.7% |
| Trade receivables | 40 | €126,699 | €162,952 | +€36,253 | +28.6% |
| Other amounts receivable | 41 | €40,547 | €38,842 | -€1,705 | -4.2% |
| Cash at bank and in hand | 54/58 | €45,128 | €12,838 | -€32,290 | -71.6% |
| Total equity and liabilities | 10/49 | €212,374 | €214,632 | +€2,258 | +1.1% |
| Equity | 10/15 | €138,808 | €132,792 | -€6,017 | -4.3% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | €118,357 | €112,340 | -€6,017 | -5.1% |
| Amounts payable | 17/49 | €73,566 | €81,841 | +€8,275 | +11.2% |
| Amounts payable within one year | 42/48 | €73,566 | €81,841 | +€8,275 | +11.2% |
| Trade debts | 44 | €21,905 | €56,299 | +€34,395 | +157% |
| Suppliers | 440/4 | €21,905 | €56,299 | +€34,395 | +157% |
| Taxes, remuneration and social security | 45 | €0 | - | = | |
| Taxes | 450/3 | €0 | - | = | |
| Other amounts payable | 47/48 | €51,661 | €25,541 | -€26,120 | -50.6% |
| Other operating charges | 640/8 | €723 | €208 | -€515 | -71.3% |
| Gross operating margin | 9900 | €31,327 | -€5,378 | -€36,705 | |
| Operating profit (loss) | 9901 | €30,604 | -€5,586 | -€36,190 | |
| Financial charges | 65/66B | €344 | €431 | +€87 | +25.4% |
| Recurring financial charges | 65 | €344 | €431 | +€87 | +25.4% |
| Profit (loss) for the period before taxes | 9903 | €30,260 | -€6,017 | -€36,277 | |
| Income taxes | 67/77 | €7,588 | €0 | -€7,588 | -100% |
| Profit (loss) for the period | 9904 | €22,672 | -€6,017 | -€28,689 | |
| Profit (loss) for the period to be appropriated | 9905 | €22,672 | -€6,017 | -€28,689 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.